Detailed in this paper is the first ever reported case of TFE3-rearranged RCC in the Philippines, with a diagnosis established using a select panel of immunohistochemical markers interpreted in correlation with classic morphological, radiologic, and clinical features. This evidence concerns the gene TFE3 and renal cell carcinoma.